Carl Dambkowski insider trades

Open-market stock purchases and sales by Carl Dambkowski, Chief Medical Officer at Apogee Therapeutics, Inc, from SEC Form 4 filings since Dec 18, 2023.

Recent trades

DateStockTradeValue
Jun 22, 2026APGE Apogee Therapeutics, IncSold$3.5M
Jun 12, 2026ORKA Oruka Therapeutics, IncSold$882K
Jun 11, 2026ORKA Oruka Therapeutics, IncSold$1.6M
Jun 3, 2026APGE Apogee Therapeutics, IncSold$433K
Jun 3, 2026APGE Apogee Therapeutics, IncBought (not open market)—
Jun 2, 2026ORKA Oruka Therapeutics, IncBought (not open market)—
May 21, 2026ORKA Oruka Therapeutics, IncSold$2.2M
May 21, 2026ORKA Oruka Therapeutics, IncSold$3.2M
May 21, 2026ORKA Oruka Therapeutics, IncSold$794K
May 21, 2026ORKA Oruka Therapeutics, IncBought (not open market)—
May 21, 2026ORKA Oruka Therapeutics, IncBought (not open market)—
May 21, 2026ORKA Oruka Therapeutics, IncBought (not open market)—
May 6, 2026APGE Apogee Therapeutics, IncSold$311K
May 6, 2026APGE Apogee Therapeutics, IncSold$152K
May 6, 2026APGE Apogee Therapeutics, IncBought (not open market)—
Apr 1, 2026APGE Apogee Therapeutics, IncSold$227K
Apr 1, 2026APGE Apogee Therapeutics, IncSold$231K
Apr 1, 2026APGE Apogee Therapeutics, IncSold$8.6K
Apr 1, 2026APGE Apogee Therapeutics, IncBought (not open market)—
Mar 4, 2026APGE Apogee Therapeutics, IncSold$14.7K
Mar 4, 2026APGE Apogee Therapeutics, IncSold$227K
Mar 4, 2026APGE Apogee Therapeutics, IncSold$149K
Mar 4, 2026APGE Apogee Therapeutics, IncBought (not open market)—
Feb 4, 2026APGE Apogee Therapeutics, IncSold$161K
Feb 4, 2026APGE Apogee Therapeutics, IncBought (not open market)—

Companies traded

  • APGE Apogee Therapeutics, Inc: 55 sales, last Jun 22, 2026
  • ORKA Oruka Therapeutics, Inc: 5 sales, last Jun 12, 2026

Get free alerts when Carl Dambkowski files a new trade →